摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

allyl (6-O-levulinoyl-2,3,4-tri-O-p-toluoyl-β-D-glucopyranosyl)-(1->3)-(4-O-acetyl-2-deoxy-2-phthalimido-β-D-galactopyranosyl)-(1->6)-[(6-O-levulinoyl-2,3,4-tri-O-p-toluoyl-β-D-glucopyranosyl)-(1->3)]-4-O-acetyl-2-deoxy-2-phthalimido-β-D-galactop... | 299189-94-9

中文名称
——
中文别名
——
英文名称
allyl (6-O-levulinoyl-2,3,4-tri-O-p-toluoyl-β-D-glucopyranosyl)-(1->3)-(4-O-acetyl-2-deoxy-2-phthalimido-β-D-galactopyranosyl)-(1->6)-[(6-O-levulinoyl-2,3,4-tri-O-p-toluoyl-β-D-glucopyranosyl)-(1->3)]-4-O-acetyl-2-deoxy-2-phthalimido-β-D-galactop...
英文别名
——
allyl (6-O-levulinoyl-2,3,4-tri-O-p-toluoyl-β-D-glucopyranosyl)-(1->3)-(4-O-acetyl-2-deoxy-2-phthalimido-β-D-galactopyranosyl)-(1->6)-[(6-O-levulinoyl-2,3,4-tri-O-p-toluoyl-β-D-glucopyranosyl)-(1->3)]-4-O-acetyl-2-deoxy-2-phthalimido-β-D-galactop...化学式
CAS
299189-94-9
化学式
C105H104N2O35
mdl
——
分子量
1953.97
InChiKey
KXPCIKNVPISGBY-GCFYGYLMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    10.09
  • 重原子数:
    142.0
  • 可旋转键数:
    37.0
  • 环数:
    14.0
  • sp3杂化的碳原子比例:
    0.37
  • 拓扑面积:
    465.97
  • 氢给体数:
    1.0
  • 氢受体数:
    35.0

反应信息

  • 作为反应物:
    描述:
    allyl (6-O-levulinoyl-2,3,4-tri-O-p-toluoyl-β-D-glucopyranosyl)-(1->3)-(4-O-acetyl-2-deoxy-2-phthalimido-β-D-galactopyranosyl)-(1->6)-[(6-O-levulinoyl-2,3,4-tri-O-p-toluoyl-β-D-glucopyranosyl)-(1->3)]-4-O-acetyl-2-deoxy-2-phthalimido-β-D-galactop...Ethyl 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-1-thio-β-D-galactopyranosideN-碘代丁二酰亚胺 、 4 A molecular sieve 、 silver trifluoromethanesulfonate 作用下, 以 甲苯 为溶剂, 反应 2.5h, 以66%的产率得到[(2R,3R,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetyloxy-2-[[(2R,3R,4R,5R,6R)-5-acetyloxy-6-[[(2R,3R,4R,5R,6R)-4,5-diacetyloxy-6-(acetyloxymethyl)-3-(1,3-dioxoisoindol-2-yl)oxan-2-yl]oxymethyl]-3-(1,3-dioxoisoindol-2-yl)-4-[(2R,3R,4S,5R,6R)-3,4,5-tris[(4-methylbenzoyl)oxy]-6-(4-oxopentanoyloxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-5-(1,3-dioxoisoindol-2-yl)-6-prop-2-enoxyoxan-4-yl]oxy-4,5-bis[(4-methylbenzoyl)oxy]-2-(4-oxopentanoyloxymethyl)oxan-3-yl] 4-methylbenzoate
    参考文献:
    名称:
    与曼氏血吸虫寄生虫循环阳极抗原的免疫反应部分有关的寡糖片段的合成和缀合
    摘要:
    循环阳极的免疫反应部分 抗原从寄生虫(CAA)曼氏血吸虫是一个苏氨酸链接 多糖由→6)-[β- D -Glc p A-(1→3)]-β- D- Gal p NAc-(1→重复组成二糖。在免疫化学项目的框架内,作为早期合成二四糖CAA片段,含间隔物的五糖片段的合成,3-(2-氨基乙硫基)丙基(2-乙酰氨基-2-脱氧-β - D-吡喃半乳糖基)-(1→6)-[(β- D-吡喃葡糖基糖醛酸)酸)-(1→3)]-(2-乙酰氨基-2-脱氧-β - D-吡喃半乳糖基)-(1→6)-[(β- D-吡喃葡糖基糖醛酸)-(1→3)]-2描述了-乙酰氨基-2-脱氧-β - D-吡喃半乳糖苷。此外,合成了1- O- [3-(2-氨基乙硫基)丙基] -N-乙酰基-β - D-半乳糖胺。氧化作用 三元合成的步骤 五糖 使用重铬酸吡啶鎓和 醋酸酐。TEMPO催化的氧化反应在合成中得到了探索。1 - O- [6-氨基己基]-β-
    DOI:
    10.1039/b002083o
  • 作为产物:
    描述:
    allyl (6-O-levulinoyl-2,3,4-tri-O-p-toluoyl-β-D-glucopyranosyl)-(1->3)-(4-O-acetyl-6-O-tert-butyldimethylsilyl-2-deoxy-2-phthalimido-β-D-galactopyranosyl)-(1->6)-[(6-O-levulinoyl-2,3,4-tri-O-p-toluoyl-β-D-glucopyranosyl)-(1->3)]-4-O-acetyl-2-deoxy... 在 对甲苯磺酸 作用下, 以 乙腈 为溶剂, 反应 0.33h, 以82%的产率得到allyl (6-O-levulinoyl-2,3,4-tri-O-p-toluoyl-β-D-glucopyranosyl)-(1->3)-(4-O-acetyl-2-deoxy-2-phthalimido-β-D-galactopyranosyl)-(1->6)-[(6-O-levulinoyl-2,3,4-tri-O-p-toluoyl-β-D-glucopyranosyl)-(1->3)]-4-O-acetyl-2-deoxy-2-phthalimido-β-D-galactop...
    参考文献:
    名称:
    与曼氏血吸虫寄生虫循环阳极抗原的免疫反应部分有关的寡糖片段的合成和缀合
    摘要:
    循环阳极的免疫反应部分 抗原从寄生虫(CAA)曼氏血吸虫是一个苏氨酸链接 多糖由→6)-[β- D -Glc p A-(1→3)]-β- D- Gal p NAc-(1→重复组成二糖。在免疫化学项目的框架内,作为早期合成二四糖CAA片段,含间隔物的五糖片段的合成,3-(2-氨基乙硫基)丙基(2-乙酰氨基-2-脱氧-β - D-吡喃半乳糖基)-(1→6)-[(β- D-吡喃葡糖基糖醛酸)酸)-(1→3)]-(2-乙酰氨基-2-脱氧-β - D-吡喃半乳糖基)-(1→6)-[(β- D-吡喃葡糖基糖醛酸)-(1→3)]-2描述了-乙酰氨基-2-脱氧-β - D-吡喃半乳糖苷。此外,合成了1- O- [3-(2-氨基乙硫基)丙基] -N-乙酰基-β - D-半乳糖胺。氧化作用 三元合成的步骤 五糖 使用重铬酸吡啶鎓和 醋酸酐。TEMPO催化的氧化反应在合成中得到了探索。1 - O- [6-氨基己基]-β-
    DOI:
    10.1039/b002083o
点击查看最新优质反应信息

文献信息

  • Synthesis of a tetrasaccharide fragment of the circulating anodic antigen of Schistosoma mansoni
    作者:Koen M. Halkes、Ted M. Slaghek、Henricus J. Vermeer、Johannis P. Kamerling、Johannes F.G. Vliegenthart
    DOI:10.1016/0040-4039(95)01162-b
    日期:1995.8
    A stereocontrolled synthesis of the allyl glycoside of a tetrasaccharide fragment of the O-linked polysaccharide chain of the circulating anodic antigen of Schistosoma mansoni, beta-D-GlcpA-(1 --> 3)-beta-D-GalpNAc-(1 --> 6)-[beta-D-GlcpA-(1 --> 3)]-beta-D-GalpNAc, is presented.
  • Preparation of spacer-containing di-, tri-, and tetrasaccharide fragments of the circulating anodic antigen of Schistosoma mansoni for diagnostic purposes
    作者:Koen M Halkes、Henricus J Vermeer、Ted M Slaghek、Peter A.V van Hooft、Arnoud Loof、Johannis P Kamerling、Johannes F.G Vliegenthart
    DOI:10.1016/s0008-6215(98)00125-6
    日期:1998.5
    The chemical synthesis of beta-D-GlcpA-(1 --> 3)-beta-D-GalpNAc-(1 --> O)CH2CH = CH2, beta-D-GalpNAc-(1 --> 6)-[beta-D-GlcpA-(1 --> 3)]-beta-D-GalpNAc-(1 --> O)CH2CH = CH2, and beta-D-GlcpA-(1 --> 3)-beta-D-GalpNAc-(1 --> 6)-[beta-D-GlcpA-(1 --> 3)]-beta-D-GalpNAc-(1 --> O)CH2CH = CH2 is described. These oligosaccharides represent fragments of the circulating anodic antigen, secreted by the parasite Schistosoma mansoni in the circulatory system of the host. The applied synthesis strategy includes the preparation of a non-oxidised backbone oligosaccharide, with a levulinoyl group at O-6 of the beta-D-glucose residue. After the selective removal of the levulinoyl group, the obtained hydroxyl functions were converted into carboxyl groups, using pyridinium dichromate and acetic anhydride in dichloromethane, to afford the desired glucuronic-acid-containing oligosaccharides. Subsequently, the allyl glycosides have been elongated with cysteamine to give the corresponding aminespacer-containing oligosaccharides. (C) 1998 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

霉酚酸苯酚beta-D-葡糖苷 阜孢霉素B 阜孢杀菌素 蔗糖棕榈酸酯 蔗糖四异硬脂酸酯 蔗糖七月桂酸酯 药喇叭(IPOMOEAPURGA)树脂 纤维素二糖八壬烷酸酯 硫脂I 石斛碱;青藤碱 甲基6-O-(2-十四烷基-3-羟基十八碳酰基)-alpha-D-吡喃葡萄糖苷 环戊羧酸,1-氨基-2-甲基-,(1R,2S)-rel- 特女贞苷 海藻糖6,6'-二甲藻酸酯 海藻糖 6,6'-二山嵛酸酯 水螅毒素 木松香II 木松香I 单岩藻糖基乳糖-N-四糖 二唾液酸乳-N-四糖 乳糖醛酸 乙醋化己二酸双淀粉 中文名称暂缺 β-D-呋喃果糖基-α-D-吡喃葡萄苷二硬脂酸酯 Β-D-呋喃果糖基-Α-D-吡喃葡糖苷十二酸双酯 alpha-D-吡喃葡萄糖苷, 6-O-(1-氧代癸基)-alpha-D-吡喃葡萄糖基, 6-癸酸酯 alpha-D-吡喃葡萄糖基-alpha-D-吡喃葡萄糖苷 6-(3-羟基-2-十四烷基十八烷酸酯) [(3aR,5R,5aR,8aS,8bR)-2,2,7,7-四甲基四氢-3aH-二[1,3]二噁唑并[4,5-b:4',5'-d]吡喃-5-基]甲基丁酸酯(non-preferredname) [(2R,3S,4S,5R,6R)-6-[(2R,3R,4S,5S,6R)-6-(十六烷酰氧基甲基)-3,4,5-三羟基四氢吡喃-2-基]氧基-3,4,5-三羟基四氢吡喃-2-基]甲基十六烷酸酯 [(2R,3S,4S,5R)-3,4-二羟基-2,5-二(羟基甲基)四氢呋喃-2-基][(2R,3S,4S,5R,6S)-3,4,5,6-四羟基四氢吡喃-2-基]甲基2-甲基-4-(2-甲基癸-1-烯-4-基)己二酸酯 [(2R,3R,4S,5R,6R)-6-[[(1R,2R,3R,4R,6R)-2,3-二羟基-5,8-二氧杂双环[4.2.0]辛烷-4-基]氧基]-3,4,5-三羟基四氢吡喃-2-基]甲基3-羟基-2-十四烷基十八烷酸酯 N-乙酰基-硫代胞壁酰-丙氨酰-异谷氨酰胺 N-(O-alpha-D-甘露糖基-(1-3)-O-(O-alpha-D-甘露糖基-(1->3)-O-(alpha-D-甘露糖基-(1-6))-alpha-D-甘露糖基-(1-6))-O-beta-D-甘露糖基-(1->4)-O-2-(乙酰氨基)-2-脱氧-beta-D-吡喃葡萄糖基-(1->4)-2-(乙酰氨基)-2-脱氧-beta-D-吡喃葡萄糖基)-L-天冬氨酰胺 L-缬氨酰-L-丙氨酰-L-缬氨酰甘氨酰-L-α-谷氨酰-L-α-谷氨酰-L-脯氨酰甘氨酰-L-脯氨酰-N~5~-(二氨基甲亚基)-L-鸟氨酸酰胺 D-甘露糖基-(1-6)-D-甘露糖基-(1-4)-2-乙酰氨基-2-脱氧-D-吡喃葡萄糖基-(1-4)-2-乙酰氨基-1-N-(4'-L-天冬氨酰)-2-脱氧-beta-D-吡喃葡萄糖基胺 D-吡喃葡糖酐-2,6-双油酸酯与聚环氧乙烷(2:1)的醚化物 D-(+)-海藻糖6-单油酸酯 9,10-二氯-2,6-二甲基蒽 8-甲氧基羰基辛基2-O-(aL-呋喃基呋喃糖基)-3-O-(aD-吡喃半乳糖基)-bD-吡喃半乳糖苷 6-山慈菇甙A 6-O-alpha-D-吡喃半乳糖基-D-葡萄糖酸 6,6'-二((2R,3R)-3-羟基-2-十四烷基十八烷酸酯)-海藻糖 4H-吡咯并[3,2,1-脱]蝶啶,5,6-二氢-4,5-二甲基-(9CI) 4-嘧啶甲腈,2-苯基- 4-[[(2R)-2-羟基-3,3-二甲基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基丁酰基]氨基]丁酸 4-[6-(1,2-二羟基乙基)-3,4,5-三羟基-四氢吡喃-2-基]氧基-2,3,5-三羟基-7,8-二氧代-辛酸 3-O-棕榈酰-beta-D-呋喃果糖基2,3-二-O-棕榈酰-alpha-D-吡喃葡萄糖苷 3-(6H-苯并[b][1,5]苯并噁噻庚英-6-基)丙基-二甲基-铵2-羟基-2-羰基-乙酸酯 2-脱氧-3-O-[(3R)-3-羟基十四烷酰基]-2-{[(3R)-3-羟基十四烷酰基]氨基}-1-O-膦酰-alpha-D-吡喃葡萄糖 2-氨基-6-[[3,5,6-三羟基-2-氧代-4-[3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基己基]氨基]己酸